Abstract
FRI-283 - A novel AFP-M2BPGi score has better performance than CRAFITY score in predicting survival for patients with viral hepatocellular carcinoma undergoing immunotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have